FDA NDC Directory

Recently listed NDCs

Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.

A listing is not an approval

The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.

Newest first

831 listings in the last 90 days

Recently listed finished products, newest first
ProductStrengthForm · routeLabelerListedProduct NDC
Ascorbic AcidAscorbic acid 500 mg/mLInjectionIntravenousRenova Pharmaceuticals LLCAug 8, 202684897-058
Terazosin HydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralApnar Pharma LPAug 7, 202624689-001
Terazosin HydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralApnar Pharma LPAug 7, 202624689-002
Terazosin HydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralApnar Pharma LPAug 7, 202624689-003
Terazosin HydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralApnar Pharma LPAug 7, 202624689-004
vancomycin hydrochloride—KitAurobindo Pharma LimitedAug 7, 202659651-669
vancomycin hydrochloride—KitAurobindo Pharma LimitedAug 7, 202659651-670
clonidine hydrochlorideClonidine hydrochloride .3 mg/1TabletOralCoupler LLCAug 7, 202667046-0646
HydrALAZINE HydrochlorideHydralazine hydrochloride 50 mg/1TabletOralCoupler LLCAug 7, 202667046-2080
Sodium BicarbonateSodium bicarbonate 84 mg/mLInjection, SolutionIntravenousMilla Pharmaceuticals Inc.Aug 7, 202671357-004
EverolimusEverolimus .25 mg/1TabletOrali3 Pharmaceuticals, LLCAug 7, 202672319-003
EverolimusEverolimus .5 mg/1TabletOrali3 Pharmaceuticals, LLCAug 7, 202672319-015
EverolimusEverolimus .75 mg/1TabletOrali3 Pharmaceuticals, LLCAug 7, 202672319-016
EverolimusEverolimus 1 mg/1TabletOrali3 Pharmaceuticals, LLCAug 7, 202672319-017
Olmesartan medoxomilOlmesartan medoxomil 5 mg/1TabletOralNorthStar RxLLCAug 7, 202672603-950
Olmesartan medoxomilOlmesartan medoxomil 20 mg/1TabletOralNorthStar RxLLCAug 7, 202672603-951
Olmesartan medoxomilOlmesartan medoxomil 40 mg/1TabletOralNorthStar RxLLCAug 7, 202672603-952
Terazosin HydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralAmerisyn LLCAug 7, 202687564-081
Terazosin HydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralAmerisyn LLCAug 7, 202687564-082
Terazosin HydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralAmerisyn LLCAug 7, 202687564-083
Terazosin HydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralAmerisyn LLCAug 7, 202687564-084
LevetiracetamLevetiracetam 100 mg/mLInjection, Solution, ConcentrateIntravenousBaxter Healthcare CorporationAug 6, 202636000-265
TolvaptanTolvaptan 15 mg/1TabletOralApotex Corp.Aug 6, 202660505-4781
TolvaptanTolvaptan 30 mg/1TabletOralApotex Corp.Aug 6, 202660505-4782
Tolvaptan—KitOralApotex Corp.Aug 6, 202660505-4800

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in